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Abstract
Introduction. An increasing number of younger patients are being hospitalized with acute coronary syndromes. Earlier 
risk assessment is essential to prevent or delay coronary artery disease (CAD). This study aimed to assess the rate, risk 
factor profile, presentation, management and prognosis in young patients with CAD and compared with the same age 
group without CAD.
Material and methods. In this retrospective study, 4325 patients who had undergone coronary angiography from 2011 
to 2014 were identified. A total of 627 patients were ≤ 45 years age; 412 of them had CAD, and 215 had normal coro-
nary arteries (control group).
Results. The mean age of the patients was 41.7 ± 4.1 years in the CAD group and 41.5 ± 4.5 years in the control group. 
The prevalences of dyslipidemia, smoking, family history of CAD, hypertension, diabetes, and overweight were higher in 
the CAD than in the control group. However, the obesity rate was not significantly different between the two groups. Pa-
tients with ACS often presented with ST elevation myocardial infarction (STEMI) (49.3%), and single-vessel involvement 
(55.3%) predominated. Percutaneous coronary intervention (PCI) was the main myocardial reperfusion therapy (68.4%).
Conclusıons. Among the young patients studied, CAD had a higher incidence in males. Smoking was the most important 
modifiable risk factor. Also, patients showed high prevalences of dyslipidemia, overweight, diabetes, and family history 
of CAD. This study re-emphasizes the relationship between traditional cardiovascular risks and CAD in young.
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Introduction
Coronary artery disease (CAD) is one of the main causes of 
morbidity and mortality worldwide. Although this condition 
usually afflicts older people, an increasing number of yo-
unger patients are being hospitalized with acute coronary 
syndromes (ACS). The prevalence of coronary atheroscle-
rosis in young adults is difficult to estimate. However, 
several studies have described the clinical profiles and 
outcomes of young adults, among which the incidence of 
the disease has been reported to range between 4% and 
10% [1–4]. Earlier risk assessment for effective cardiovas-
cular disease prevention is essential to prevent or delay 
coronary calcification, which has been shown to predict 
subsequent coronary heart disease. In general, young 
patients are more likely to be male and to have a history 
of smoking, hyperlipidemia, and cocaine use but are less 
likely to have other comorbidities, such as hypertension, 
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ction was done in all patients. The results were classified 
according to systolic function as normal (LVEF ≥ 50%), 
mild-moderate LV dysfunction (LVEF of 35–50%), or severe 
LV dysfunction (LVEF < 35%).
The major clinical outcomes (in-hospital and long-term) 
analyzed in our study included all cause mortality, conge-
stive heart failure (New York Heart Association classes 
II–IV), recurrent ischemia/reinfarction, major arrhythmic 
events, cardiogenic shock, major bleeding, and stroke.
The study was approved by the local ethics committee.
Statistical analysis
Continuous variables were expressed as mean ± SE of 
mean. Dichotomous variables were expressed as counts 
and percentages. Differences in baseline characteristics 
were compared by using Student’s t test and the χ2 test. 
Calculations were done with the use of the SPSS software 
(version 16.0; SPSS, Inc., Chicago, Illinois). All P values were 
2-sided and considered statistically significant at P < 0.05.
Results
Clinical characteristics
The mean ages at presentation were 41.7 ± 4.1 and 41.5 
± 4.5 years in the CAD and the control group, respectively. 
Tables 1 and 2 show the baseline clinical characteristics 
and laboratory findings for the study population. Patients 
with CAD were more likely to present with chest pain 
(95.6%) and less likely to have heart failure (Killip classes 
II to IV in 3.4%) and arrhythmia (1%). There was no signi-
ficant difference between the two groups regarding age, 
blood pressure and heart rate at first admission, BMI, LDL 
values, and hypertension. The young patients with CAD had 
higher prevalences of smoking, male gender, family history 
of CAD, DM, previous CAD, and TG values but showed lower 
HDL levels. A few patients had a history of peripheral artery 
disease, prior cerebral stroke, and chronic renal failure. The 
prevalence of overweight was higher among young patients 
with CAD than in the control group (p = 0.008), whereas 
the difference in the prevalence of obesity between the 
two groups was not statistically significant (p = 0.188). 
Diabetes was more frequent in the CAD group (p < 0.001), 
and patients with CAD had higher serum glucose levels 
(p = 0.00) at first admission. The mean troponin-I level in 
the CAD group was 22.8 ± 33.1 µg/L. Echocardiography 
during hospitalization revealed that the mean LV function 
was significantly decreased in patients with CAD compared 
with the control group (p = 0.00).
Angiographic features
The majority of patients in the CAD group presented with 
STEMI, with a slightly higher rate of anterior MI. The most 
patients had single-vessel disease and left main disease 
(LMCA). Based on the angiographic analysis, 35 patients 
diabetes mellitus (DM), or prior CAD [1, 2, 5–10]. We there-
fore investigated the CAD frequency, risk factors, presenting 
symptoms, treatment, angiographic findings, implications, 
and in-hospital outcomes among young patients undergo-
ing coronary angiography in our hospital.
Materials and methods
Study population in this retrospective study included 4325 
patients who had undergone coronary angiography in our 
hospital from 01 January 2011 to 30 September 2014. 
A total of 627 patients were ≤ 45-years-old and had ACS 
or stable angina pectoris with ischemia documented by 
exercise testing or myocardial perfusion scintigraphy. The 
cutoff age of 45 years has been previously used to define 
young patients. A total of 412 young patients showed 
coronary artery stenosis in the initial angiogram, and 215 
patients had normal coronary arteries. We compared those 
patients who had CAD (CAD group) with those who showed 
normal coronary arteries (control group).
Data on the patients’demographic characteristics, 
risk factors, presenting signs and symptoms, blood inve-
stigation, number of diseased coronary vessels, ejection 
fraction (EF), complications, and in-hospital outcomes 
were retrospectively collected from clinical records and 
analyzed. The ACS definition included ST elevation my-
ocardial infarction (STEMI), non-ST elevation myocardial 
infarction (NSTEMI), and unstable angina (UA). Coronary 
angiography was done in all patients because of ACS or 
stable angina with ischemia documented by exercise tes-
ting or myocardial perfusion scintigraphy. Also, coronary 
angiography was done to investigate the etiology of heart 
failure and arrhythmia. Angiographic stenosis was defined 
as a 70% or greater decrease in the diameter of a major 
epicardial coronary vessel or a decrease greater than 50% 
in the diameter of the left main coronary artery (LMCA). DM 
was defined as history of DM treated with medication, or 
a fasting blood glucose level of 126 mg/dL or two casual 
plasma glucose readings of 200 mg/dL. Hypertension 
was defined as blood pressure greater than 140 mm Hg 
systolic or 90 mm Hg diastolic on at least two occasions 
or receiving any antihypertensive drug. Hyperlipidemia 
was defined as history of dyslipidemia diagnosed and/or 
treated, low-density lipoprotein (LDL)-cholesterol greater 
than or equal to 130 mg/dL, high-density lipoprotein (HDL)-
-cholesterol < 40 mg/dL in men or < 50 mg/dL in women, 
or hypertriglyceridemia (TG ≥ 150 mg/dL). Current smoker 
was defined as a person who smoked cigarettes within 
1 month. A family history of CAD was defined as evidence of 
CAD in a parent, sibling, or children before 55 years of age. 
Overweight was defined as body mass index (BMI) greater 
than 25 kg/m2, and obesity as BMI greater than 30 kg/m2. 
Renal impairment was defined as serum creatinine ≥ 2 mg/dL. 
Echocardiographic assessment of the left ventricular fun-
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Table 1. Baseline clinical characteristics for the study population
Parameter CAD group Control group p
Age 41.7 ± 4.1 41.5 ± 4.5 0.505
Male [%] 349 (84.7) 126 (58.6) 0.001
Body weight [kg] 82.5 ± 13.4 79.2 ± 15.3 0.010
BMI [kg/m2] 28.2 ± 3.7 28.1 ± 5.1 0.990
Overweight [BMI ≥ 25 kg/m2] [%] 310 (83.8) 123 (74.1) 0.008
Obesity [BMI ≥ 30 kg/m2] [%] 104 (28.1) 56 (33.2) 0.188
Smoking [%] 333 (80.8) 100 (46.5) 0.001
DM type II [%] 112 (27.2) 26 (12.1) 0.001
DM type I [%] 5 (1.2) 0 0.105
Hypertension [%] 122 (29.6) 46 (21.4) 0.029
Dyslipidemia [%] 334 (81.1) 141 (65.6) 0.001
Chronic kidney disease [%] 9 (2.2) 0 0.029
Previous CAD [%] 68 (16,5) 0 0.001
Heart failure [%] 54 (13.1) 10 (4.7) 0.001
History of CVA [%] 6 (1.5) 0 0.075
Family history [%] 132 (33.8) 61 (23.2) 0.020
Illegal drug use [%] 7 (1.7) 0 0.147
PAD [%] 6 (1.5) 0 0.075
Presentation [%]:
• typical angina 393 (95.6) 209 (97.2) 0.030
• STEMI 203 (49.3)
• NSTEMI 100 (24.2)
• USAP 83 (20.1) 128 (59.7) 0.001
• stable angina pectoris 18 (4.4) 81 (37.5) 0.001
• Killip class II or IV 15 (3.4) 3 (1.4) 0.001
• arrhythmias 4 (1) 3 (1.4) 0.010
BMI — body mass index; DM — diabetes mellitus; CAD — coronary artery disease; CVA — cardiovascular accident; PAD — peripheral artery disease; STEMI — ST-elevation myocardial infarction; NSTEMI — non-
-ST-elevation myocardial infarction; USAP — unstable angina pectoris
Table 2. Laboratory analysıs of the first hospital admission in the study population
Laboratory analysis CAD group Control group p
Hemoglobin [mg/dL] 14.4 ± 5.4 14.6 ± 10.3 0.808
Triglyceride [mg/dL] 214.9 ± 177 173.1 ± 133.4 0.003
HDL [mg/dL] 32.2 ± 9.7 42.7 ± 11.8 0.000
LDL [mg/dL] 131.3 ± 43.2 125 ± 36.2 0.600
CRP [mg/L] 12.9 ± 21.7 9.8 ± 19.2 0.439
Troponin 22.8 ± 33 0.1 ± 0.8 0.000
Glucose [mg/dL] 138 ± 71 108 ± 40 0.000
Creatıne 1.02 ± 1.23 0.77 ± 0.46 0.005
Echocardiography (LVEF) 48.3 ± 9.6 57.1 ± 7.8 0.000
Ejextion fraction < 35% 54 (13.1) 10 (4.7) 0.001
HDL — high-density lipoprotein; LDL — low-density lipoprotein; CRP — C-reactive protein; LVEF — left ventricular ejection fraction
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with ACS had less than 50% stenosis, and 6 patients with 
ACS had normal coronary arteries. Only one coronary 
artery anomalies (circumflex artery (CX) originating from 
the right coronary sinus) was identified. The angiography 
revealed normal coronary arteries with slow coronary flow 
in pregnant patient with inferior MI who was admitted to 
the emergency department as a case of cardiopulmonary 
arrest. Also coronary artery dissection observed in the left 
anterior descending artery (LAD) in patient with 39-week 
pregnant. Although the mortality is higher in this patient 
group, she survived the three-year follow-up. Seven patients 
had a history of recreational drug use, but that may not 
be the exact number of social causes. Factor V Leiden 
mutation was identified in one patient.
The patients received revascularization treatments, 
including thrombolytic therapy (43 patients), PCI (282 pa-
tients), and CABG (38 patients). Primary PCI was the main 
myocardial reperfusion therapy in STEMI and was done in 
155 patients (37.6%). The success rate of percutaneous 
procedures was very high (approaching 97%) in the young 
patients, and that of primary PCI was 94.8%. Acute stent 
thrombosis occurred in 5 patients, and subacute stent throm-
bosis was detected in 11 patients, complicating STEMI during 
hospitalization. The rescue PCI was applied in 10 patients. 
Elective or emergent CABG was needed in 38 patients, and 
60 patients were treated medically. During the long-term 
follow-up, recurrent MI developed in 33 patients, 13 of 
whom showed chronic stent restenosis. Table 3 shows the 
angiographic findings, treatment, and reperfusion strategies.
In-hospital outcome and discharge diagnosis
The duration of hospital stay in the CAD group was 4.1 ± 
± 2.2 days. Sixty-nine patients (16.7%) with STEMI in whom 
percutaneous angioplasty was done received glycoprotein 
IIb/IIIa inhibitors. The rates of complications and mortality 
were lower during the hospitalization period. Fourteen 
patients in the CAD group had heart failure (Killip classes 
II to IV); cardiogenic shock occurred in 3 of these patients, 
requiring intra-aortic balloon counterpulsation for hemo-
dynamic support. The in-hospital mortality was low, with 
only 2 deaths. None of the young patients had contrast 
nephropathy, sepsis, LV mechanical complications, such 
as septum/free wall rupture, embolism, or stroke. The 
incidence of major arrhythmic events, especially ventricu-
lar arrhythmia, was 7.2%. On discharge from the hospital, 
clinical heart failure required diuretics was considered in 
54 (13.1%) of the young patients with CAD although half 
of the patients with CAD had preserved LVEF. During the 
mean followup period of 27 months (range, 8–54 months), 
33 patients (8.09%) developed recurrent MI. Two patients 
developed apical thrombus, but none of the patients had 
a stroke. Table 4 shows the medical treatment and clinical 
outcomes of patients with ACS during their hospital stay 
and in the follow-up period.
Discussion
The prevalence of CAD in young patients have reported 
between 4% and 10 %depending on the cutoff age used; 
this is in accordance with the 9.52% prevalence in our study 
population [1–4]. The recently increased prevalance of CAD 
in young adults can be partly attributed to the increased 
prevalence of risk factors for atherosclerosis. Previous 
studies have reported that young patients with CAD had 
higher proportions of males, smoking, overweight, hyperli-
pidemia, and family history of CAD but lower incidences of 
hypertension and DM [1, 2, 5–10]. However, most of these 
studies compared young patients with older ones. Our study 
results were in accordance with those previous findings 
and reinforce the role of conventional risk factors in young 
patients . Male sex was more prevalent, and risk factors, 
such as tobacco use, overweight, hyperlipidemia, DM, and 
hypertension, were more frequent in young patients with 
CAD compared with the control group. In addition, the 
statistical significance was less determined between the 
two groups in terms of hypertension, and LDL-cholesterol.
Table 3. Coronary angiographic features, treatment and reperfu-
sion strategies in patients with coronary artery disease (CAD)
CAD group
Number of diseased vessels
LMCA 3 (0.7%)
Single-vessel 230 (55.3%)
Two-vessel 107 (26%)
Multiple-vessel 28 (6.8%)
Minimal CAD 35 (8.5%)
Normal CAD 6 (1.5%)
Coronary artery ectasia 3 (0.7%)
Coronary slow flow 3 (0.7%)
Coronary reperfusion strategies
Primary PCI 155 (37.6%)
Rescue PCI 10 (2.4%)
Electıve 117 (28.4%)
Initial success of primary PCI 147 (94.8%)
Thrombolytic therapy 43 (10.4%)
Elective or emergent CABG 38 (9.2%)
Medical follow up 60 (14.6%)
Infarct-related artery in primary PCI
LAD 94 (60%)
LCX 14 (9.07%)
RCA 47 (30.3%)
LMCA — left main coronary artery; PCI — percutaneous coronary intervention; CABG — coronary 
artery bypass surgery; LAD — left anterior descending artery LCX — left circumflex artery; RCA — 
right coronary artery
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Cigarette smoking was found to be the most com-
mon modifiable risk factor. The role of smoking in the 
pathogenesis of MI in young people is well-established, 
with most studies reporting that between 75% to 90% 
of young patients with acute MI are smokers [1–5, 9]. 
In the Framingham Heart Study, Kannel et al. [11] found 
the relative risk for CAD to be thrice higher in smokers of 
ages 35–44 years compared with nonsmokers. This was 
confirmed in the present study, in which 80.8% of the 
patients had a history of tobacco use, and the prevalence 
of smoking was more than twice as high among patients 
with CAD compared with controls.
The incidence of lipid abnormalities, especially high TG 
and low HDL cholesterol, was also a higher in patients with MI 
who were less than 45-years-old [4, 12, 13]. Fasting serum 
TG levels are usually inversely related to HDL levels, and 
hypertriglyceridemia is an independent risk factor beyond 
LDL cholesterol [4]. Thus, it can be concluded that high TG, 
which may be the primary lipid abnormality with or without 
low HDL levels and normal/high LDL levels in young adults, 
is a matter of concern. Also HDL-C are an important para-
meter for predicting the risk and the clinical outcomes of 
AMI in young male patients [13]. In our study, 81.1% of the 
patients had dyslipidemia. Although the LDL cholesterol level 
did not differ between the two groups, the TG concentration 
was higher and the HDL cholesterol level was lower in the 
CAD group, in accordance with previous findings [4, 12, 13].
Overweight and obesity lead to many health conditions, 
such as DM, hypertension, hyperlipidemia, and heart 
disease [14]. Although overweight is not considered to 
be a certain risk factor for MI, it has been suggested to 
be a potential independent risk factor for MI in a young 
population [15]. Although the frequency of obesity was not 
significantly different between two groups the prevalence 
of overweight was significantly higher in the CAD group. 
Thus, our results suggested that being overweight might 
be a potential risk factor for MI in young populations.
The prevalence of DM in young patients was lower than 
in the non-young [6–9], moreover, it has been found to be 
frequently present in young CAD patients [14–16]. In this 
study, the prevalence of DM (mainly type 2) was twice as 
high in the CAD group than in the control group. In addition, 
the prevalence of DM was slightly higher compared with 
that reported in previous studies [6, 7]. Although insulin-
-dependent DM is a high risk factor for CAD, type 1 DM 
was found only in 5 young CAD patients, a lower number 
than in previous studies [14, 16]. Apart from overt diabe-
tes, impaired glucose tolerance was found in 65% of MI 
survivors less than 45 years old, as reported in a previous 
study [17]; however, there are no data related to insulin 
resistance in the present study.
Family history of premature MI is a factor known to be 
present in many of young patients and probably represent 
a combination risk factors of CAD that are genetically de-
termined [1, 8]. It has previously been shown that children 
whose family members had premature CAD tended to have 
greater insulin resistance, more lipid abnormalities, and 
higher incidences of obesity [18]. In a study carried out 
among young patients in London, positive family history 
was found in 39% of the participants [19]. Similarly, we 
Table 4. Medical treatment and clinical outcomes in patients with 
acute coronary syndrome during their hospital stay and follow-up
CAD group
Medical treatment
Glycoprotein IIb/IIIa inhibitors 69 (16.74%)
Heparin 155 (37.6%)
Low-molecular-weight heparin 183 (44.4%)
Aspirin 400 (97.1%)
Clopidogrel 327 (79.4%)
ACEI/ARB 288 (69.9%)
Beta-blocker 324 (78.8%)
Statin 335 (81.5%)
Diuretic 25 (6.06%)
Hospital outcomes
Length of hospital stay [day] 4.1 ± 2.2
In-hospital mortality 2 (0.4%)
Ventricular arrhythmia 24 (5.8%)
Atrioventricular block 3 (0.7%)
Paroxysmal atrial fibrillation 2 (0.4%)
Cardiac rupture/tamponade 0
Bleeding complications 2 (0.4%)
Acute renal failure 1 (0.24%)
Infection 0
Stent thrombosis
Acute 5 (1.2%)
Subacute 11 (2.7%)
Stroke 0
Clinical heart failure
Killip I 50 (12.1%)
Killip II–III 12 (2.7%)
Cardiogenic shock 3 (0.72%)
Long-term outcome
Repeated PCI 31 (7.5%)
Chronic stent restenosis 13 (4.7%)
Recurrent myocardial infarction 33 (8.1%)
Overall mortality 5 (1.2%)
Left ventricular apical thrombus 2 (0.5%)
ACEI — angiotensin-converting enzyme inhibitors; ARB — angiotensin receptor blockers; PCI — per-
cutaneous coronary intervention
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found family history in 38% of the patients; however, there 
was no statistically significantly difference between two 
groups.
Angina that rapidly progress to acute MI is a common 
clinical presentation of CAD in young adults [2, 19]. The 
prevalence of stable angina is rare; it was found to be 
24% in only one study and the duration of symptoms was 
reported to be less than a week in most patients [19]. Our 
study results indicated that young patients had an acute 
onset of symptoms, the prevalence of stable angina was 
4.4%, 20.1% of patients had UA, and more than half of the 
patients were admitted with MI as the first sign of CAD. 
Only 24.5% of the cohort had a history of angina before 
MI; this trend is consistent with the results of Imazio et al. 
[20]. Therefore, CAD identification and intervention before 
MI is difficult in unsuspecting young patients.
Single-vessel disease was more common than multiple-
-vessel disease, and the prevalence of normal or minor 
coronary artery abnormalities was higher in young patients 
with CAD [1, 9]. Similarly, we found that young patients 
with MI have less extensive CAD, with a significant inciden-
ce of single-vessel disease. Also, the incidence of LMCA 
disease was very low in the young population. Multivessel 
lesions were present mainly in those who had several risk 
factors, especially DM. Normal or minor vascular disease 
was found in 10% of the patients.
Besides atherosclerotic CAD, non-atherosclerotic CAD 
or hypercoagulability such as pregnancy, carcinoma, poly-
cythemia, nephrotic syndrome, collagen tissue disorder, 
oral contraceptive use, antiphospholipid syndrome, and 
factor V Leiden deficiency should be considered in young 
cases of MI [1, 2, 21]. Coronary artery spasm, whish is 
associated that recognise with the use of cocaine and 
alcohol may also play a role in initiating coronary occlusion 
and infarction [22, 23]. Non-atherosclerotic spontaneous 
coronary artery dissection (SCAD) is a rare cause of acute 
coronary syndrome; young women are at higher risk of 
SCAD, particularly in the peripartum or early postpartum 
period [24]. Coronary artery abnormalities are quite rare 
and it can initially present as MI in young adults [25]. 
A history of congenital coagulation disorders was found 
in only two patients. Drug use was reported by only seven 
patients (1.7%), a lower number than in other studies. It 
is because of drug use could not be questioned exactly 
and ıt was rejected by the social reasons. Connective 
tissue disorders were not found. The MI prevalence in 
a normal coronary angiogram was low (approximately 3%) 
but seemed to vary with age, with higher rates in young 
patients [1].
The rate of in-hospital complications and mortality 
are low in young ACS patients due to their low-risk profile 
with usually have no concomitant disorders, less severe 
CAD, better cardiac reserve function, and the application 
of early revascularization with a better response to PCI 
[1, 3, 5, 9, 10]. Consistent with these studies, the rates 
of complications and mortality during the hospitalization 
period were low in most of our patients. The compliance 
to treatment in the hospital and at home was high among 
patients with CAD (Table 4).
Study limitations
This study had certain limitations. First, it was done retro-
spectively, and the data on patients were obtained from 
medical records, which were incomplete. Second, only 
conventional risk factors for CAD were evaluated; other, 
newer risk factors, such as lipoprotein abnormalities, hy-
percoagulable states, and hyperhomocysteinemia, were not 
studied. Third, data on the use of cocaine or sympathomi-
metic agents were not available. Finally, nonatherosclerotic 
coronary disease was not directly evaluated, and there was 
no attempt to document the presence of coronary vaso-
spasm by ergonovine stimulation in patients with normal 
coronary arteries.
Conclusion
This study emphasized that in a general population of 
the same age and sex, young patients with CAD were 
often smokers and overweight. They also had low-
-HDL cholesterol levels, hypertriglyceridemia, and DM. 
Patients commonly had an acute onset of symptoms, 
less extensive CAD, and a favorable prognosis. Besides 
atherosclerotic CAD, non-atherosclerotic CAD, such as 
congenital coronary abnormalities, coronary aneurysm, 
coronary dissection, or hypercoagulability, should be 
considered as an etiologic factor in young patients with 
MI despite its rare appearance. Consequently, it seems 
that smoking and components of metabolic syndrome, 
such as overweight, hypertriglyceridemia, and low HDL-C 
level, are important modifiable risk factors that commu-
nity health service providers should focus on to come 
up with primary measures to prevent heart attacks in 
young adults.
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Streszczenie
Wstęp. Coraz więcej młodych osób jest hospitalizowanych z powodu ostrych zespołów wieńcowych (ACS). Wczesna oce-
na ryzyka ma podstawowe znaczenie w zapobieganiu chorobie wieńcowej (CAD) lub opóźnieniu jej wystąpienia. Badanie 
przeprowadzono w celu oceny częstości występowania CAD, jej czynników ryzyka, objawów, leczenia oraz rokowania 
u młodych pacjentów z CAD i porównanie tych danych z odpowiednimi danymi dotyczącymi osób niechorujących na CAD.
Materiał i metody. Na potrzeby tego retrospektywnego badaniu zidentyfikowano 4325 chorych poddanych koronaro-
grafii w latach 2011–2014. W grupie badanych było 627 chorych w wieku nie więcej niż 45 lat; u 412 osób z tej grupy 
stwierdzono CAD, a u 215 obraz tętnic wieńcowych był prawidłowy (grupa kontrolna).
Wyniki. Średni wiek chorych wynosił 41,7 ± 4,1 roku w grupie CAD i 41,5 ± 4,5 roku w grupie kontrolnej. W grupie CAD 
stwierdzono częstsze występowanie dyslipidemii, palenia tytoniu, dodatniego wywiadu rodzinnego odnośnie do CAD, 
nadciśnienia tętniczego, cukrzycy i otyłości niż w grupie kontrolnej. Jednak różnica w zakresie częstości występowa-
nia otyłości nie była istotna statystycznie. U chorych z ACS często stwierdzano zawał serca z uniesieniem odcinka ST 
(49,3%), a dominującym typem zmian w koronarografii była choroba jednonaczyniowa (55,3%). Najczęściej stosowanym 
leczeniem reperfuzyjnym (68,4%) była przezskórna interwencja wieńcowa.
Wnioski. W badanej grupie młodych pacjentów stwierdzono większą zapadalność na CAD wśród mężczyzn. Najważniej-
szym poddającym się modyfikacji czynnikiem ryzyka było palenie tytoniu. U dużej części chorych stwierdzono również 
dyslipidemię, otyłość, cukrzycę i występowanie CAD w rodzinie. Badanie ponownie zwróciło uwagę na zależność między 
tradycyjnymi czynnikami ryzyka sercowo-naczyniowego a występowaniem CAD w młodym wieku.
Słowa kluczowe: choroba wieńcowa, młodzi dorośli, koronarografia
Folia Cardiologica 2017; 12, 6: 543–550
prese ntation, treatment and outcome. Int J Cardiol. 2011; 148(3): 
300–304, doi: 10.1016/j.ijcard.2009.11.009, indexed in Pub-
med: 19942306.
8. Matsis K, Holley A, Al-Sinan A, et al. Differing clinical characteris-
tics between young and older patients presenting with myocardial 
ınfarction. Heart Lung Circ. 2017; 26(6): 566–571, doi: 10.1016/j.
hlc.2016.09.007, indexed in Pubmed: 28089789.
9. Shah N, Kelly AM, Cox N, et al. Myocardial infarction in the “young”: 
risk factors, presentation, management and prognosis. Heart Lung 
Circ. 2016; 25(10): 955–960, doi: 10.1016/j.hlc.2016.04.015, in-
dexed in Pubmed: 27265644.
10. Fournier JA, Sánchez-González A, Quero J, et al. Normal angiogram 
after myocardial infarction in young patients: a prospective clini-
cal-angiographic and long-term follow-up study. Int J Cardiol. 1997; 
60(3): 281–287, doi: 10.1016/s0167-5273(97)00115-0, indexed in 
Pubmed: 9261639.
11. Kannel W, McGee D, Castelli W. Latest perspectives on cigarette 
smoking and cardiovascular disease: the Framingham Study. J Card 
Rehabil. 1984; 4: 267–77.
12. Cullen P. Evidence that triglycerides are an independent coronary 
heart disease risk factor. Am J Cardiol. 2000; 86(9): 943–949, in-
dexed in Pubmed: 11053704.
13. Li Z, Huang Ji, Li N. Predictive and prognostic value of high-density li-
poprotein cholesterol in young male patients with acute myocardial ın-
farction. Chin Med J (Engl). 2017; 130(1): 77–82, doi: 10.4103/0366-
6999.196581, indexed in Pubmed: 28051027.
14. Mahoney LT, Burns TL, Stanford W, et al. Usefulness of the Framin-
gham risk score and body mass index to predict early coronary ar-
tery calcium in young adults (Muscatine Study). Am J Cardiol. 2001; 
References
1. Zimmerman FH, Cameron A, Fisher LD, et al. Myocardial infarction in 
young adults: angiographic characterization, risk factors and progno-
sis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol. 1995; 
26(3): 654–661, doi: 10.1016/0735-1097(95)00254-2, indexed in 
Pubmed: 7642855.
2. Doughty M, Mehta R, Bruckman D, et al. Acute myocardial infarction 
in the young — the University of Michigan experience. Am Heart J. 
2002; 143(1): 56–62, doi: 10.1067/mhj.2002.120300, indexed in 
Pubmed: 11773912.
3. Morillas P, Bertomeu V, Pabón P, et al. PRIAMHO II Investigators. 
Characteristics and outcome of acute myocardial infarction in young 
patients. The PRIAMHO II study. Cardiology. 2007; 107(4): 217–225, 
doi: 10.1159/000095421, indexed in Pubmed: 16953107.
4. Akosah KO, Schaper A, Cogbill C, et al. Preventing myocardial infarc-
tion in the young adult in the first place: how do the National Choles-
terol Education Panel III guidelines perform? J Am Coll Cardiol. 2003; 
41(9): 1475–1479, doi: 10.1016/s0735-1097(03)00187-6, indexed 
in Pubmed: 12742284.
5. Barbash GI, White HD, Modan M, et al. Acute myocardial infarction 
in the young--the role of smoking. The Investigators of the Interna-
tional Tissue Plasminogen Activator/Streptokinase Mortality Trial. 
Eur Heart J. 1995; 16(3): 313–316, doi: 10.1093/oxfordjournals.
eurheartj.a060912, indexed in Pubmed: 7789372.
6. Shiraishi J, Kohno Y, Yamaguchi S, et al. AMI-Kyoto Multi-Center Risk 
Study Group. Acute myocardial infarction in young Japanese adults. 
Circ J. 2005; 69(12): 1454–1458, doi: 10.1253/circj.69.1454, in-
dexed in Pubmed: 16308491.
7. Schoenenberger AW, Radovanovic D, Stauffer JC, et al. AMIS 
Plus Investigators. Acute coronary syndromes in young patients: 
550
Folia Cardiologica 2017, vol. 12, no. 6
www.journals.viamedica.pl/folia_cardiologica
88(5): 509–515, doi: 10.1016/s0002-9149(01)01728-3, indexed in 
Pubmed: 11524059.
15. Uhl GS, Farrell PW. Myocardial infarction in young adults: risk fac-
tors and natural history. Am Heart J. 1983; 105(4): 548–553, 
doi: 10.1016/0002-8703(83)90476-3, indexed in Pubmed: 6837409.
16. Krolewski AS, Kosinski EJ, Warram JH, et al. Magnitude and deter-
minants of coronary artery disease in juvenile-onset, insulin-de-
pendent diabetes mellitus. Am J Cardiol. 1987; 59(8): 750–755, 
doi: 10.1016/0002-9149(87)91086-1, indexed in Pubmed: 3825934.
17. Malmberg K, Båvenholm P, Hamsten A. Clinical and biochemical fac-
tors associated with prognosis after myocardial infarction at a young 
age. J Am Coll Cardiol. 1994; 24(3): 592–599, doi: 10.1016/0735- 
-1097(94)90002-7, indexed in Pubmed: 8077526.
18. British Heart Foundation. BHF coronary heart disease statistics 
2003. http://www.bhf.org.uk/professionals/statistics (2003).
19. Chen L, Chester M, Kaski JC. Clinical factors and angiographic fea-
tures associated with premature coronary artery disease. Chest. 
1995; 108(2): 364–369, doi: 10.1378/chest.108.2.364, indexed in 
Pubmed: 7634868.
20. Imazio M, Bobbio M, Bergerone S, et al. Clinical and epidemiological 
characteristics of juvenile myocardial infarction in Italy: the GISSI 
experience. G Ital Cardiol. 1998; 28(5): 505–512, indexed in Pub-
med: 9646064.
21. Mansourati J, Da Costa A, Munier S, et al. Prevalence of factor V 
Leiden in patients with myocardial infarction and normal coronary 
angiography. Thromb Haemost. 2000; 83(6): 822–825, indexed in 
Pubmed: 10896232.
22. Isner JM, Estes NA, Thompson PD, et al. Acute cardiac events tem-
porally related to cocaine abuse. N Engl J Med. 1986; 315(23): 
1438–1443, doi: 10.1056/NEJM198612043152302, indexed in 
Pubmed: 3785295.
23. Huang CN, Wu DJ, Chen KS. Acute myocardial infarction caused by 
transnasal inhalation of amphetamine. Jpn Heart J. 1993; 34(6): 
815–818, doi: 10.1536/ihj.34.815, indexed in Pubmed: 8164349.
24. Neves D, Bento Â, Fernandes R, et al. Spontaneous coronary ar-
tery dissection: still a lot to learn. Rev Port Cardiol. 2017; 36(1): 
59.e1–59.e5, doi: 10.1016/j.repc.2016.06.012, indexed in Pub-
med: 27988230.
25. Harikrishnan S, Jacob SP, Tharakan J, et al. Congenital coronary 
anomalies of origin and distribution in adults: a coronary arterio-
graphic study. Indian Heart J. 2002; 54(3): 271–275, indexed in 
Pubmed: 12216922.
